Overview

Human Vasodilatory Effect of GLP-1

Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
Comprehensive assessment of human vasodilatory effect of GLP-1 in forearm and coronary arteries
Phase:
N/A
Details
Lead Sponsor:
Papworth Hospital NHS Foundation Trust
Treatments:
Glucagon-Like Peptide 1